Elevation Oncology, Inc.·4

Jun 22, 6:45 PM ET

Walsh Colin 4

4 · Elevation Oncology, Inc. · Filed Jun 22, 2022

Insider Transaction Report

Form 4
Period: 2022-06-17
Walsh Colin
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-17+15,61915,619 total
    Exercise: $1.31Exp: 2032-06-16Common Stock (15,619 underlying)
Footnotes (1)
  • [F1]The entire award will vest on the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION